Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

QUEENS GEM

Financiado

Cerrado

Quartromicins; Enantioselective Total Synthesis and Generating Molecular Librari...

Quartromicins; Enantioselective Total Synthesis and Generating Molecular Libraries of Drug-like Bioactive Compounds. Nature is an indispensable source of bioactive compounds, but not necessarily an ideal provider of bulk or analogs. Total synthesis plays an important role in generating new analogs of natural molecules and as a means to reduce de... ver más

31/10/2025

CNRS

196K€

Presupuesto del proyecto: 196K€

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-02

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CNRS

195.91K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-117025RB-I00 BUSQUEDA Y MEJORA DE 2DESOXIRRIBOSIL TRANSFERASAS MEDIANTE... 132K€ Cerrado

CTQ2009-13590 MACROLIDE-LIKE ANTITUMOR AND ANTIVIRAL AGENTS-TOTAL SYNTHESE... 218K€ Cerrado

ANTIBIOTICS DOS Diversity Oriented Synthesis of Peptide Derivatives as Antib... 172K€ Cerrado

CTQ2011-29285-C02-01 DISEÑO ASISTIDO POR ORDENADOR Y SINTESIS DE NUEVOS INHIBIDOR... 74K€ Cerrado

CTQ2008-06200 DISEÑO, DESARROLLO SINTETICO, ESTUDIO BIOFISICO Y EVALUACION... 48K€ Cerrado

SEQUENCING Reaction Sequencing A concise asymmetric approach to the an... 169K€ Cerrado

Duración del proyecto: 29 meses Fecha Inicio: 2023-05-02
Fecha Fin: 2025-10-31

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 196K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Nature is an indispensable source of bioactive compounds, but not necessarily an ideal provider of bulk or analogs. Total synthesis plays an important role in generating new analogs of natural molecules and as a means to reduce dependency on natural resources. The outbreak of COVID-19 and other viruses has posed a significant global threat, the urgent need arises to study and discover new antiviral. It has become imperative for researchers to develop strategic research plans in order to synthesize medicines to combat these viruses. Quartromicins are well known for their antiviral properties but barely explored due to no known synthesis to date and low isolation yield (0.36-0.06%) makes them an attractive target molecule for the total synthesis for further investigation and development to combat the viruses. With this proposal, we address the synthetic aspects of the main bioactive molecules and their analogs being considered to be repositioned for the effective treatment of viral infections. The first total synthesis of Quartromicins A1, A2, A3, D1, D2, D3 is proposed by a convergent synthetic strategy that involves the use of an enantioselective Diels-Alder reaction, the carbonyl-ene reaction mediated by organocatalyst, and the Heck dimerizing coupling reaction as the key step to the macrocyclization. The endo adduct is proposed to be readily synthesized by the enantioselective Diels-Alder reaction while the exo unit by a carbonyl-ene reaction, both mediated by the organocatalyst. The exo & endo fragments are proposed to be transformed to the corresponding exo & endo-spirotetronate fragments by simple organic transformations. Finally, the symmetrical Quartromicins A1, A3, D1 & D3 and unsymmetrical Quartromicins A2 & D2 can be synthesized by the Heck dimerizing coupling and the Heck double cross-coupling reactions respectively. The late-stage glycosylation strategy shall furnish a library of bioactive molecules essential for medicinal chemistry applications.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores